← Leaderboards
Terry Van Dyke
Division Of Basic Sciences - Nci
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Division Of Basic Sciences - Nci
Same institution · by research overlap
Others in their field
Top investigators on “Mouse Model”
- Dennis R. Burton · Scripps Research Institute$280,661,242
- David Heimbrook · Leidos Biomedical Research, Inc.$84,491,283
- Kc Kent Lloyd · University Of California At Davis$74,285,556
- Alan F Horwitz · University Of Virginia Charlottesville$73,668,592
- Stanley B Prusiner · University Of California San Francisco$61,905,394
- Ed Lein · Allen Institute$59,425,748
Research focus
Mouse ModelTumorMalignant NeoplasmsPathway InteractionsGenetically Engineered MouseCellsMolecularTissuesPre-ClinicalAnimalsIn VivoResponseGeneticStagingTumorigenesisPharmaceutical PreparationsDesignBaseAstrocytomaMutantCohortDisease ProgressionImageIn Vitro
Grant awards (70)
Animal Model Development-CAPR infrastructure$1,397,013
ZIC · FY2015 · CA · contact PI
Development of GEM and GDA models of Pancreatic Adenocarcinoma$963,457
ZIA · FY2015 · CA · contact PI
Evaluation of therapeutic efficacy in mouse melenoma models$722,593
ZIA · FY2015 · CA · contact PI
Preclinical Characterization of Drugs in Mouse Model of Lung Cancer$481,728
ZIA · FY2015 · CA · contact PI
Preclinical GEM and GDA Models of Primary and Metastatic Melanoma$481,728
ZIA · FY2015 · CA · contact PI
Development of ESiPSC approach for non-germline GEM modeling$240,865
ZIA · FY2015 · CA · contact PI
Validation of, and therapeutic evaluation in ovarian cancer GEM models$240,865
ZIA · FY2015 · CA · contact PI
Therapeutic evaluation in GEM pancreatic model$240,865
ZIA · FY2015 · CA · contact PI
Pathway Analysis in Mouse Model for Astrocytoma via Systems Biology Approach$48,173
ZIA · FY2015 · CA · contact PI
Preclinical Characterization of Drugs in Mouse Model of Lung Cancer$1,012,184
ZIA · FY2014 · CA · contact PI
Development and validation of preclinical mouse model for serous ovarian cancer$1,012,184
ZIA · FY2014 · CA · contact PI
Rb TS inhibition dedifferentiates astrocytes leading to Astrocytoma initiation$840,990
ZIA · FY2014 · CA · contact PI
Center for Applied Preclinical Research (CAPR)$809,748
ZIC · FY2014 · CA · contact PI
The study of underlying mechanism of EGFR-Ras signaling in glioblastoma$560,659
ZIA · FY2014 · CA · contact PI
Investigate the role of EGFR and PDGFR regulated pathways in GBM tumorigenesis$504,593
ZIA · FY2014 · CA · contact PI
Analysis of genetic changes associated with astrocytomagenesis$420,494
ZIA · FY2014 · CA · contact PI
Pathway Analysis in Mouse Model for Astrocytoma via Systems Biology Approach$404,874
ZIA · FY2014 · CA · contact PI
Establishing the Preclinical Model for Metastatic Melanoma$404,874
ZIA · FY2014 · CA · contact PI
Development of ESiPSC approach for non-germline GEM modeling$202,437
ZIA · FY2014 · CA · contact PI
Mechanisms of Prostate Tumorigenesis Using Genetically Engineered Mouse Models$140,165
ZIA · FY2014 · CA · contact PI
Mechanisms of Early Stage Mammary Tumorigenesis$140,165
ZIA · FY2014 · CA · contact PI
Systems biology study of astrocytomagenesis$140,165
ZIA · FY2014 · CA · contact PI
Therapeutic evaluation in GEM pancreatic model$121,462
ZIA · FY2014 · CA · contact PI
Adoption and Retooling of GEM model for Pancreatic Cancer$80,975
ZIA · FY2014 · CA · contact PI
The Mechanism of Thymic Lymphomagenesis in Genetically Engineered Mouse Model$56,066
ZIA · FY2014 · CA · contact PI
Preclinical Characterization of Drugs in Mouse Model of Lung Cancer$848,130
ZIA · FY2013 · CA · contact PI
Development and validation of preclinical mouse model for serous ovarian cancer$848,130
ZIA · FY2013 · CA · contact PI
Center for Applied Preclinical Research (CAPR)$678,504
ZIC · FY2013 · CA · contact PI
Rb TS inhibition dedifferentiates astrocytes leading to Astrocytoma initiation$519,127
ZIA · FY2013 · CA · contact PI
Mechanisms of Early Stage Mammary Tumorigenesis$519,127
ZIA · FY2013 · CA · contact PI
Mechanisms of Prostate Tumorigenesis Using Genetically Engineered Mouse Models$519,127
ZIA · FY2013 · CA · contact PI
The study of underlying mechanism of EGFR-Ras signaling in glioblastoma$519,127
ZIA · FY2013 · CA · contact PI
Establishing the Preclinical Model for Metastatic Melanoma$339,253
ZIA · FY2013 · CA · contact PI
Pathway Analysis in Mouse Model for Astrocytoma via Systems Biology Approach$339,253
ZIA · FY2013 · CA · contact PI
Investigate the role of EGFR mutation and amplification in GBM tumorigenesis$259,563
ZIA · FY2013 · CA · contact PI
The Mechanism of Thymic Lymphomagenesis in Genetically Engineered Mouse Model$259,563
ZIA · FY2013 · CA · contact PI
Development of ESiPSC approach for non-germline GEM modeling$169,626
ZIA · FY2013 · CA · contact PI
Therapeutic evaluation in GEM pancreatic model$101,775
ZIA · FY2013 · CA · contact PI
Adoption and Retooling of GEM model for Pancreatic Cancer$67,850
ZIA · FY2013 · CA · contact PI
Preclinical Characterization of Drugs in Mouse Model of Lung Cancer$1,051,828
ZIA · FY2012 · CA · contact PI
Development and validation of preclinical mouse model for serous ovarian cancer$1,051,828
ZIA · FY2012 · CA · contact PI
Center for Applied Preclinical Research (CAPR)$841,462
ZIC · FY2012 · CA · contact PI
The study of underlying mechanism of EGFR-Ras signaling in glioblastoma$652,207
ZIA · FY2012 · CA · contact PI
Rb TS inhibition dedifferentiates astrocytes leading to Astrocytoma initiation$652,207
ZIA · FY2012 · CA · contact PI
Mechanisms of Early Stage Mammary Tumorigenesis$652,207
ZIA · FY2012 · CA · contact PI
Mechanisms of Prostate Tumorigenesis Using Genetically Engineered Mouse Models$652,207
ZIA · FY2012 · CA · contact PI
Establishing the Preclinical Model for Metastatic Melanoma$420,730
ZIA · FY2012 · CA · contact PI
Pathway Analysis in Mouse Model for Astrocytoma via Systems Biology Approach$420,730
ZIA · FY2012 · CA · contact PI
The Mechanism of Thymic Lymphomagenesis in Genetically Engineered Mouse Model$326,103
ZIA · FY2012 · CA · contact PI
Characterization of the invading cells in glioblastoma$326,103
ZIA · FY2012 · CA · contact PI
Adoption and Retooling of GEM model for Pancreatic Cancer$210,366
ZIA · FY2012 · CA · contact PI
Development of ES/iPSC approach for non-germline GEM modeling$210,366
ZIA · FY2012 · CA · contact PI
Development and validation of preclinical mouse model for serous ovarian cancer$1,449,087
ZIA · FY2011 · CA · contact PI
Preclinical Characterization of Drugs in Mouse Model of Lung Cancer$1,242,074
ZIA · FY2011 · CA · contact PI
The study of underlying mechanism of EGFR-Ras signaling in glioblastoma$1,192,695
ZIA · FY2011 · CA · contact PI
Mechanisms of Prostate Tumorigenesis Using Genetically Engineered Mouse Models$894,521
ZIA · FY2011 · CA · contact PI
Center for Applied Preclinical Research (CAPR)$828,050
ZIC · FY2011 · CA · contact PI
Mechanisms of Early Stage Mammary Tumorigenesis$596,348
ZIA · FY2011 · CA · contact PI
Pathway Analysis in Mouse Model for Astrocytoma via Systems Biology Approach$414,025
ZIA · FY2011 · CA · contact PI
The Mechanism of Thymic Lymphomagenesis in Genetically Engineered Mouse Model$298,174
ZIA · FY2011 · CA · contact PI
Development of ESiPSC approach for non-germline GEM modelling$207,012
ZIA · FY2011 · CA · contact PI
Preclinical Characterization of Drugs in Mouse Model of Lung Cancer$1,329,129
ZIA · FY2010 · CA · contact PI
The study of underlying mechanism of EGFR-Ras signaling in glioblastoma$1,168,070
ZIA · FY2010 · CA · contact PI
Center for Applied Preclinical Research (CAPR)$1,107,608
ZIC · FY2010 · CA · contact PI
Development and validation of preclinical mouse model for serous ovarian cancer$1,107,608
ZIA · FY2010 · CA · contact PI
Pathway Analysis in Mouse Model for Astrocytoma via Systems Biology Approach$886,086
ZIA · FY2010 · CA · contact PI
Mechanisms of Prostate Tumorigenesis Using Genetically Engineered Mouse Models$876,052
ZIA · FY2010 · CA · contact PI
Mechanisms of Early Stage Mammary Tumorigenesis$584,034
ZIA · FY2010 · CA · contact PI
The Mechanism of Thymic Lymphomagenesis in Genetically Engineered Mouse Model$292,018
ZIA · FY2010 · CA · contact PI
Center for Applied Preclinical Research (CAPR)$1,817,445
ZIC · FY2009 · CA · contact PI